New malaria test kit gives a boost to elimination efforts worldwide

LAMP test will also improve diagnosis for imported UK cases

2013-05-17

(Press-News.org) A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to new research published in the Journal of Infectious Diseases.

In two studies led by researchers in the UK and Switzerland, the new LAMP (loop-mediated isothermal amplification) test was compared to existing methods in London laboratories that deal with imported cases of malaria to the UK, and to diagnostic methods used in the field in Uganda, where malaria is a leading cause of illness and death.

The simple test, which can be performed by a non-specialist health worker and does not need refrigerating like other tests, requires a sample of blood to be processed and placed in a test tube with a reactive powder then heated. If the malaria-causing Plasmodium parasites are present, the tube glows green. The whole process takes less than an hour.

The first study, led in London by the Hospital for Tropical Diseases (HTD), the London School of Hygiene & Tropical Medicine and the Foundation for Innovative New Diagnostics (FIND), compared LAMP to existing laboratory diagnostic methods on 705 blood samples of suspected imported malaria cases in the UK.

Dr Colin Sutherland, Clinical Scientist at HTD and Reader in Parasitology at the Malaria Reference Laboratory at the London School of Hygiene & Tropical Medicine, said: "According to data collected for Public Health England by the London School of Hygiene & Tropical Medicine, the UK treats at least 1,500 cases of imported malaria every year. Despite the very best efforts of the NHS, a handful of malaria related deaths still occur annually in UK hospitals. The new LAMP test for malaria performed very well when tested in the parasite reference laboratory at HTD, and correctly identified every malaria patient out of 705 malaria tests performed.

"An important advantage of LAMP is that non-specialist staff in any hospital in the UK will be able to accurately and rapidly detect the presence of malaria parasites, and immediately begin treatment without waiting for confirmation from local experts or specialist laboratories. This speed of diagnosis can make the difference between an uncomplicated episode of malaria that rapidly responds to treatment, and progression to severe disease, organ failure and heightened risk of death. It could also save the NHS a significant amount of money from having to treat the complications of malaria."

LAMP was faster than PCR (polymerase chain reaction) tests, which require specialised laboratory equipment, costly reagents and advanced training. It was also more accurate than microscopic examination of blood slides, which require a trained specialist to identify the malaria parasites.

In the second study, researchers from HTD, FIND, the London School of Hygiene & Tropical Medicine and the Uganda Ministry of Health, Kampala, looked at the accuracy of the test at a rural clinic in Uganda.

Blood samples from 272 patients with suspected malaria were tested using LAMP using a simple generator to provide electrical current. These results were compared with expert microscopy and PCR performed at central reference laboratories. LAMP detected cases of low-level malaria parasite infection that were missed by expert microscopy, and achieved accuracy similar to that of PCR down to very low levels. The researchers say these findings have important implications for eliminating malaria, which causes an estimated 660,000 deaths worldwide every year.

Dr Sutherland, who worked on both of the studies, said: "Patterns of malaria disease in Africa and elsewhere across the tropics are becoming much less predictable, and control of malaria needs an appropriate test to identify infected individuals in the populations at risk. These people may not display any malaria symptoms. We have begun using LAMP as a new tool for identifying "hot spots" of malaria infections which can be mopped up quickly through a combination of drug treatment, house spraying and distribution of bed-nets.

"LAMP will potentially contribute to saving many families and communities from the blight of a disease that keeps children from succeeding at school, prevents adults from growing food or working, holds back regional economies and exacts an annual death toll in the hundreds of thousands."

The LAMP malaria test will now be used in the Malaria Reference Laboratory at the London School of Hygiene & Tropical Medicine to help identify imported cases of malaria in the UK as well as being used by health workers in the field in malaria endemic countries.

### The LAMP malaria test is commercially available and was developed by the Foundation for Innovative New Diagnostics, the Hospital for Tropical Diseases, London and Eiken Chemical Company Ltd, Japan. The studies were funded by the Bill and Melinda Gates Foundation, the Ministry of Foreign Affairs of the Government of The Netherlands, and the UK Department for International Development.

For further information or to request interviews, please contact the London School of Hygiene & Tropical Medicine press office on +44 (0) 207 297 2802 or press@lshtm.ac.uk.

First study: Polley, González, Mohamed, Daly, Bowers, Watson, Armstrong, Gray, Perkins, Bell, Kanda, Tomita, Kubota, Mori, Chiodini, Sutherland. Clinical Evaluation of a LAMP test kit for Diagnosis of Imported Malaria. Journal of Infectious Diseases. DOI: 10.1093/infdis/jit183 Second study: Hopkins, González, Polley, Angutoko,Ategeka, Asiimwe, Agaba, Kyabayinze, Sutherland, Perkins, Bell. Highly sensitive detection of malaria parasitemia in an endemic setting: Performance of a new LAMP kit in a remote clinic in Uganda. Journal of Infectious Diseases. DOI: 10.1093/infdis/jit184

London School of Hygiene & Tropical Medicine The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with 3,500 students and more than 1,000 staff working in over 100 countries. The School is one of the highest-rated research institutions in the UK, and was recently cited as one of the world's top universities for collaborative research. The School's mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. http://www.lshtm.ac.uk

Hospital for Tropical Diseases Part of UCLH (University College London Hospitals NHS Foundation Trust), the Hospital for Tropical Diseases is the only hospital dedicated to tropical and infectious diseases within the NHS. It offers expert advice, diagnosis and treatment for a wide range of infectious and travel-related illnesses including parasites, malaria, leprosy, and diseases of the skin, eye and gut. The hospital serves long and short-term travellers and immigrants It has a daily walk-in emergency clinic for tropical diseases as well as a rapid-access clinic for infectious diseases, specialist outpatient clinics and a clinic for pre-travel advice and vaccinations. For more information visit http://www.uclh.nhs.uk/OurServices/OurHospitals/UCH/HTD/Pages/Home.aspx

Foundation for Innovative New Diagnostics The Foundation for Innovative New Diagnostics (FIND) is dedicated to developing affordable, easy-to-use, cutting edge diagnostic tests that save lives in the poorest areas of the world. From proof of principle to putting new tests into practice, the organization works with diverse groups, including academia, industry, donors, partners in the field, Ministries of Health and the World Health Organization. With new diagnostics for malaria, tuberculosis and sleeping sickness already in use, FIND is also working on other neglected diseases such leishmaniasis, Chagas disease, and other causes of acute fever. Launched in 2003, the not-for-profit Foundation is ISO certified and financed by both the private and public sectors, including the Bill & Melinda Gates Foundation, the governments of the Netherlands and Germany, the European Union, UNITAID, UK Department for International Development, National Institutes of Health (USA), UBS Optimus Foundation and others.

Eiken Eiken Chemical Co., Ltd., has over 60 years of experience in medical diagnostics, and was the first Japanese company to successfully commercialize the manufacture of powdered culture media for microbiological investigations. The company has established itself as a leader in the clinical diagnostics market, and has a strong commitment to research and development toward products and technologies that fill needs at the cutting edge of contemporary medicine. The LAMP technology, developed at Eiken in 1998, is now a core technology being exploited to develop a range of products. http://www.eiken.co.jp/en/

ELSE PRESS RELEASES FROM THIS DATE:

Clinical support for patient self-management is rhetoric rather than reality

2013-05-17

The processes to allow people to self-manage their own illness are not being used appropriately by health professionals to the benefit of their patients, new research suggests. Self-management support aims to increase the patient's ability to take ownership over their condition and in some cases, to self-treat. It is widely seen as critical to ensure the sustainability of health services in terms of costs. Although potentially effective, patient based interventions can be limited as not all patients engage with them. However, embedding self-management support discussions ...

The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation

2013-05-17

May 17, 2013, Shenzhen, China---- Why Tibetan antelope can live at elevations of 4,000-5,000m on the Qinghai-Tibetan Plateau? In a collaborative research published in Nature Communications, investigators from Qinghai University, BGI, and other institutes provide evidence that some genetic factors may be associated with the species' adaption to harsh highland environments. The data in this work will also provide implications for studying specific genetic mechanisms and the biology of other ruminant species. The Tibetan antelope (Pantholops hodgsonii) is a native of the ...

New discovery of ancient diet shatters conventional ideas of how agriculture emerged

2013-05-17

Archaeologists have made a discovery in southern subtropical China which could revolutionise thinking about how ancient humans lived in the region. They have uncovered evidence for the first time that people living in Xincun 5,000 years ago may have practised agriculture –before the arrival of domesticated rice in the region. Current archaeological thinking is that it was the advent of rice cultivation along the Lower Yangtze River that marked the beginning of agriculture in southern China. Poor organic preservation in the study region, as in many others, means that ...

Promising doped zirconia

2013-05-17

Materials belonging to the family of dilute magnetic oxides (DMOs) — an oxide-based variant of the dilute magnetic semiconductors — are good candidates for spintronics applications. This is the object of study for Davide Sangalli of the Microelectronics and Microsystems Institute (IMM) at the National Research Council (CNR), in Agrate Brianza, Italy, and colleagues. They recently explored the effect of iron (Fe) doping on thin films of a material called zirconia (ZrO2 oxide). For the first time, the authors bridged the gap between the theoretical predictions and the experimental ...

SUMO wrestling cells reveal new protective mechanism target for stroke

2013-05-17

Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival. The discovery, made by researchers from the University's School of Biochemistry and published in the EMBO journal with additional comment in Nature Reviews, could eventually lead to new therapies for stroke and other brain diseases. The research builds on earlier work by the team which identified a protein, known as SUMO, responsible for controlling the chemical processes which ...

New study pinpoints biochemical mechanism underlying fibrosis following glaucoma surgery

2013-05-17

Philadelphia, PA, May 17, 2013 – The most common cause of failure after glaucoma surgery is scarring at the surgical site, so researchers are actively looking for ways to minimize or prevent scar formation. Previous work had suggested that vascular endothelial growth factor (VEGF) activates fibrosis, whereas VEGF inhibition results in reduced scar formation and better surgical results. In a series of studies using a rabbit model of glaucoma surgery, investigators have determined that VEGF probably exerts its effects through induction of transforming growth factor (TGF)-β1, ...

Stroke patients respond similarly to after-stroke care, despite age difference

2013-05-17

Athens, Ga. – Age has little to do with how patients should be treated after suffering a stroke, according to new research from the University of Georgia. Historically, younger stroke victims receive different after-stroke intervention strategies than those over a certain age. However, Neale Chumbler, a UGA professor and head of the department of health policy and management in the College of Public Health, found patients responded equally to care efforts. Looking at 127 Veterans Affairs medical centers and a sample of 3,196 patients treated for ischemic strokes, ...

Study: Patient openness to research can depend on race and sex of study personnel

2013-05-17

CINCINNATI—Researchers at the University of Cincinnati (UC) have found that the race and sex of study personnel can influence a patient's decision on whether or not to participate in clinical research. The study, presented today at the Society for Academic Emergency Medicine's annual meeting in Atlanta, that there is an interaction of the race and sex of the study assistant and the race of the patient. Lead author Kimberly Hart says that her team found that black patients, both male and female, were about 15 percent less likely to be willing to participate in research ...

Study: Peer-referral programs can increase HIV-testing in emergency departments

2013-05-17

CINCINNATI—Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the hospital for testing. Co-author and assistant professor of emergency medicine Michael Lyons, MD, says public health officials study multiple approaches to increasing early diagnosis of HIV. These approaches include a recent emphasis on expanding testing in health care centers, particularly emergency departments (EDs) that treat disadvantaged, ...

LDL cholesterol is a poor marker of heart health in patients with kidney disease

2013-05-17

Among patients with chronic kidney disease, those with very low kidney function had a higher risk of having a heart attack than those with higher kidney function over a four-year period. The link between higher LDL cholesterol and heart attack risk was weaker for patients with very low kidney function than for patients with higher kidney function. 60 million people globally have chronic kidney disease. Washington, DC (May 16, 2013) — LDL cholesterol is not a useful marker of heart disease risk in patients with kidney disease, according to a study appearing in an upcoming ...

New malaria test kit gives a boost to elimination efforts worldwide

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: